Pierluigi Paracchi

AurorA Science is a biotech investment company integrating an Innovative financial and industrial approach in research and development. The company is focused on independent and entrepreneurial biotech start-ups with high therapeutic potential. AurorA Science is the result of the partnership between the technology transfer company AurorA-TT and two strategic industrial partners and investors, Rottapharm Biotech and Italfarmaco, who share in-house R&D facilities and expertise to support the development of portfolio companies and create the ideal conditions for partnering with bio-pharma companies. The company focus is the support of final pre-clinical activities and early clinical developments throughout investment exit.

InnovUp is the association that represents the Italian ecosystem of innovation and that connects startups, scaleups, innovative SMEs, innovation centers, science and technology parks, incubators, accelerators, enablers, investors, professional firms and corporates. InnovUp works to unite and foster the Italian innovative entrepreneurship system, focusing on 4 main areas of activity: Lobbying, Knowledge, Business, Networking.

Altheia Science is a pioneering start-up founded by two world renowned Italian scientists, Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD, together with AurorA-TT. Altheia Science’s pipeline exploits pioneering therapeutic tools for autoimmune diseases and cancer. The modulation of PD-L1 expression at the molecular and protein level is key to devise advanced treatments. This can be achieved by first-in-class molecules controlling the PD-L1 pathway and/or by lentiviral vector-based engineering of patients’ hematopoietic stem cells. Altheia Science’s approach intends to drastically modify the natural history of diseases with high clinical impact in autoimmunity and cancer by modulating PD-L1 expression, achieving tangible and durable benefit for each patient.

SÒPHIA HIGH TECH, certified according to the Aerospace Quality Standard AS/EN9100, was born from the deep vocation for product development. SÒPHIA operates in the Aerospace & Defense field, extremely focused on the design, development and manufacturing of metal alloy parts using Additive Manufacturing (3D Printing) and CNC Machining. SÒPHIA Manufacturing Department uses the most forefront technological processes to produce advances Space components (i.e: Combustion Chambers, Thrusters, Nozzles and Fuel Tankers) made by INCONEL718, ensuring the process qualification acc. to the ECSS-Q-ST-70-80C (ESA-30July2021). SÒPHIA works also with stainless steel, copper alloys, aluminum and titanium alloys. All Customers define SOPHIA as “reliable" Company, because it builds a solid and continuous partnership that always leads a win-win approach, based on “problem solving”. Complex engineering analysis and structural optimization are the challenges we face every day!

Nearly 6.800 firms located in the Provinces of Milan, Lodi, Pavia and Monza and Brianza are associated to Assolombarda, which is the largest territorial association of the entire entrepreneurial system in the country. Assolombarda is part of Confindustria (Italian Entrepreneurial Association). The associated firms employ about 400.000 workers locally and several hundred thousands in the whole country. The mission of the Association is to protect and represent the enterprises'​ interests in dealing with the political world, with social and political organizations and with local authorities as well as with trade unions. Assolombarda also provides its associated firms with a great variety of services. Furthermore, assistance, advice and practical handbooks are supplied on several management and strategy aspects. Follow us on: Web Magazine: www.genioeimpresa.it Twitter: @Assolombarda Facebook: Assolombarda Instagram: assolombarda Youtube: AssolombardaTV

AurorA Science is a biotech investment company integrating an Innovative financial and industrial approach in research and development. The company is focused on independent and entrepreneurial biotech start-ups with high therapeutic potential. AurorA Science is the result of the partnership between the technology transfer company AurorA-TT and two strategic industrial partners and investors, Rottapharm Biotech and Italfarmaco, who share in-house R&D facilities and expertise to support the development of portfolio companies and create the ideal conditions for partnering with bio-pharma companies. The company focus is the support of final pre-clinical activities and early clinical developments throughout investment exit.

InnovUp is the association that represents the Italian ecosystem of innovation and that connects startups, scaleups, innovative SMEs, innovation centers, science and technology parks, incubators, accelerators, enablers, investors, professional firms and corporates. InnovUp works to unite and foster the Italian innovative entrepreneurship system, focusing on 4 main areas of activity: Lobbying, Knowledge, Business, Networking.

Altheia Science is a pioneering start-up founded by two world renowned Italian scientists, Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD, together with AurorA-TT. Altheia Science’s pipeline exploits pioneering therapeutic tools for autoimmune diseases and cancer. The modulation of PD-L1 expression at the molecular and protein level is key to devise advanced treatments. This can be achieved by first-in-class molecules controlling the PD-L1 pathway and/or by lentiviral vector-based engineering of patients’ hematopoietic stem cells. Altheia Science’s approach intends to drastically modify the natural history of diseases with high clinical impact in autoimmunity and cancer by modulating PD-L1 expression, achieving tangible and durable benefit for each patient.